Philips Reports Q3 2026 Growth Driven by Order Intake and Margin Expansion
Philips (PHG) reported strong third-quarter 2026 results, characterized by a 3% increase in comparable sales growth and an 8% rise in equipment order intake. The company saw significant momentum in its Diagnosis and Treatment segment, which experienced nearly 20% growth in order intake, alongside steady gains in Personal Health and Connected Care sectors. Profitability improved with an adjusted EBITA margin of 13%, a 70 basis point expansion driven by productivity measures and innovation-led gross margin improvements. Free cash flow saw a substantial boost to EUR 384 million compared to the previous year. Despite these gains, the company recorded a EUR 288 million legal provision related to an agreement with the U.S. Department of Justice regarding Respironics. Management reiterated full-year sales guidance of 3% to 4.5% growth and adjusted EBITA margin guidance of 13.5% to 14%. The company continues to focus on its long-term productivity target of EUR 1.5 billion in savings by 2028, while transitioning toward recurring revenue models through 'Monitoring as a Service.'
Tickers: $PHG
Topics: earnings report free cash flow profitability revenue growth
Read the full article at Motley Fool
Part of the story Philips Reports Q3 2026 Growth Driven by Order Intake and Margin Expansion (10 articles)